Citialfa Injection
Marketer
Alniche Life Sciences Pvt Ltd
Salt Composition
Citicoline (250mg/ml)
Overview Citialfa Injection
Citialfa Injection treats stroke, head trauma, Alzheimer's disease, and Parkinson's disease-related memory impairment (dementia). Its mechanism involves safeguarding brain neurons from harm and facilitating their repair, thus enhancing cognitive function. Administered intravenously by a medical professional, it's reserved for situations where oral intake is infeasible. Follow your physician's prescribed dosage and schedule; if a dose is missed, take it promptly upon recollection. Potential side effects include hypotension, abdominal discomfort, diarrhea, arrhythmia, skin rash, sleep disturbances, and exacerbated numbness in affected limbs. Injection site reactions (pain, erythema, edema) may also occur, but are usually transient and self-limiting. Persistent or troublesome side effects warrant medical attention. Prior to commencing treatment, disclose any kidney issues, seizure history (epilepsy), pregnancy, pregnancy plans, or breastfeeding to your doctor. Dosage is individualized based on age and diagnosis; always inform your doctor of all concurrent medications.
Uses of Citialfa Injection
Managing stroke, head trauma, Alzheimer's disease, and Parkinson's-related dementia.
Major Benefits of Citialfa Injection:
Administering this medication will be handled by your physician or their nursing staff; self-medication is strictly prohibited.
Common Side effects of Citialfa Injection:
- Injection site reactions (pain, swelling, redness)
- Decreased blood pressure
- Arrhythmia (irregular heartbeats)
- Stomach pain
- Diarrhea
- Insomnia (difficulty in sleeping)
- Rash
- Peripheral neuropathy (tingling and numbness of feet and hand)
How to use Citialfa Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Citialfa Injection works:
Citialfa Injection safeguards nerve cells, fostering their health and survival. This is achieved through the production of key neurochemicals, such as phosphatidylcholine and acetylcholine, while simultaneously mitigating the accumulation of free fatty acids at nerve injury sites.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption while using Citialfa Injection is undetermined. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Data on Citialfa Injection use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Citialfa Injection use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Citialfa Injection on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should receive Citialfa Injection with careful monitoring. The Citialfa Injection dosage might require modification. A physician's consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Citialfa Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Citialfa Injection :
NA
Facts to Know About Citialfa Injection
| Label | Value |
|---|---|
| Type of Compound | Diphosphate pyrimidine ribonucleoside |
| Potential for Dependence | None. |
| Type of Treatment | Nervous system medications |
| Mechanism of Action | Cognitive enhancer |

